| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2002;74:328-332
© 2002 The Society of Thoracic Surgeons
a Division of Thoracic and Foregut Surgery and Minimally Invasive Surgery Center, University of Pittsburgh Medical Center Health System, Pittsburgh, Pennsylvania, USA
* Address reprint requests to Dr Luketich, Division of Thoracic and Foregut Surgery, UPMC Presbyterian, 200 Lothrop St, Suite C-800, Pittsburgh, PA 15213 USA
e-mail: luketichjd{at}msx.upmc.edu
Presented at the Forty-eighth Annual Meeting of the Southern Thoracic Surgical Association, San Antonio, TX, Nov 8–10, 2001.
Background. Reoperative antireflux surgery is complex and traditionally performed by open methods. Increasingly, surgeons are performing minimally invasive reoperations. This report summarizes our experience with laparoscopic reoperative antireflux surgery (LRAS).
Methods. A retrospective review (1996 to 2001) identified 80 LRAS cases. Median age was 49 (22 to 80) years with 52 females and 28 males. Primary symptoms included heartburn (53%), regurgitation (22%), and dysphagia (25%). Detailed outcomes recorded at follow-up included heartburn severity using the Gastroesophageal Reflux Disease-Health Related Quality of Life scale (HRQOL) and SF36 physical (PCS) and mental (MCS) component summary scores.
Results. LRAS was completed in 97.5% of cases (two conversions). The most common problems identified were mediastinal migration of the wrap in 48 (60%) and misplaced wrap in 11 (13.8%). LRAS operations included Collis-Nissen (42), Nissen (26), Toupet (six), and six others. Pyloroplasty was required in nine (11%). Complications occurred in 16 patients. These included nine minor gastric perforations (all repaired intraoperatively) and two reoperations for complications (1 patient with a bile leak and the second with a pyloroplasty site leak). Median length of stay was 2.5 days. Median follow-up was 18 (1 to 52) months; 18 (23%) required proton-pump inhibitors. Detailed outcomes were available in 50 patients. Mean PCS and MCS scores were 42 and 47, respectively (normals = 50). HRQOL scores were excellent in 35 (65%), satisfactory in 9 (17%), and poor in 10 (18%). Ten patients (18%) reported that they were dissatisfied.
Conclusions. LRAS can be performed safely with complication and success rates similar to open operations in a center with extensive laparoscopic experience.
This article has been cited by other articles:
|
|
 |
|
  O. Awais, J. D. Luketich, J. Tam, K. Irshad, M. J. Schuchert, R. J. Landreneau, and A. Pennathur Roux-en-Y near esophagojejunostomy for intractable gastroesophageal reflux after antireflux surgery. Ann. Thorac. Surg., June 1, 2008; 85(6): 1954 - 1959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Luketich and A. Pennathur How to Keep the Treatment of Esophageal Disease in the Surgeon's Hands Ann. Thorac. Surg., February 1, 2008; 85(2): S760 - S763. [Full Text] [PDF]
|
|
|
|
|
|
A. Nieponice, T. W. Gilbert, and S. F. Badylak Reinforcement of Esophageal Anastomoses With an Extracellular Matrix Scaffold in a Canine Model Ann. Thorac. Surg., December 1, 2006; 82(6): 2050 - 2058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. C. Fernando, J. D. Luketich, J. Samphire, M. Alvelo-Rivera, N. A. Christie, P. O. Buenaventura, and R. J. Landreneau Minimally Invasive Operation for Esophageal Diverticula Ann. Thorac. Surg., December 1, 2005; 80(6): 2076 - 2080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. A. Khan, G. Kanellopoulos, M. L. Field, K. R. Knowles, F. D. Beggs, W. E. Morgan, and J. P. Duffy Redo antireflux surgery--the importance of a tailored approach Eur. J. Cardiothorac. Surg., November 1, 2004; 26(5): 875 - 880. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
